News Future uncertain for Innate and BMS' troubled lirilumab Doubts over future of cancer immunotherapy
News Tesaro gets European approval on Zejula, set to challenge AZ Tesaro's PARP drug approved in wider ovarian cancer population
News Samsung Bioepis Herceptin biosimilar approved in EU Mylan and Biocon resolve biosimilar manufacturing issues
News Roche double trial success could expand use of two new drugs A double trial success from Roche sees it eyeing a combination therapy in lucrative first-line lung cancer, and wider use of its just-approved haemophilia drug, Hemlibra.
News FDA approves Roche potential haemophilia blockbuster Blood cancer drug Gazyva also gets new US use
News US regulator approves new use for Pfizer's Sutent FDA granted new kidney cancer indication despite advisers' split decision
News Obesity needs a new clinical definition, study finds The current definition of obesity based on BMI isn't nuanced enough to gauge health and the need for weight-loss therapies, according to a new study.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
